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Background. Obesity is a major health problem. Although heritability is substantial, genetic mechanisms predisposing to
obesity are not very well understood. We have performed a genome wide association study (GWA) for early onset (extreme)
obesity. Methodology/Principal Findings. a) GWA (Genome-Wide Human SNP Array 5.0 comprising 440,794 single
nucleotide polymorphisms) for early onset extreme obesity based on 487 extremely obese young German individuals and 442
healthy lean German controls; b) confirmatory analyses on 644 independent families with at least one obese offspring and
both parents. We aimed to identify and subsequently confirm the 15 SNPs (minor allele frequency $10%) with the lowest p-
values of the GWA by four genetic models: additive, recessive, dominant and allelic. Six single nucleotide polymorphisms
(SNPs) in FTO (fat mass and obesity associated gene) within one linkage disequilibrium (LD) block including the GWA SNP
rendering the lowest p-value (rs1121980; log-additive model: nominal p=1.13610
27, corrected p=0.0494; odds ratio (OR)CT
1.67, 95% confidence interval (CI) 1.22–2.27; ORTT 2.76, 95% CI 1.88–4.03) belonged to the 15 SNPs showing the strongest
evidence for association with obesity. For confirmation we genotyped 11 of these in the 644 independent families (of the six
FTO SNPs we chose only two representing the LD bock). For both FTO SNPs the initial association was confirmed (both
Bonferroni corrected p,0.01). However, none of the nine non-FTO SNPs revealed significant transmission disequilibrium.
Conclusions/Significance. Our GWA for extreme early onset obesity substantiates that variation in FTO strongly contributes
to early onset obesity. This is a further proof of concept for GWA to detect genes relevant for highly complex phenotypes. We
concurrently show that nine additional SNPs with initially low p-values in the GWA were not confirmed in our family study,
thus suggesting that of the best 15 SNPs in the GWA only the FTO SNPs represent true positive findings.
Citation: Hinney A, Nguyen TT, Scherag A, Friedel S, Bro ¨nner G, et al (2007) Genome Wide Association (GWA) Study for Early Onset Extreme Obesity
Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants. PLoS ONE 2(12): e1361. doi:10.1371/journal.pone.0001361
INTRODUCTION
The advent of genome wide association studies (GWAs) already has
had a major impact on the identification of polygenes involved in
human body weight regulation [1]. However, a GWA based on
obese cases and lean controls has not yet been described. GWA have
recently proven extremely powerful for the detection of genes/SNPs
for different complex disorders [2,3]. The progress has been
particularly impressive for type 2 diabetes mellitus (T2DM) [4–7].
FTO was one of the genes picked up in GWA studies for T2DM
[5,6], adjustment for BMI revealed that this effect was solely based
onthisquantitativephenotype[5].WeperformedaGWA(Genome-
Wide Human SNP Array 5.0; Affymetrix) on patient samples
stemming from both ends of the BMI distribution and subsequently
aimed to confirm the 15 GWA SNPs with minor allele frequency
(MAF) $10% rendering the lowest p-values determined upon
analysis of four genetic models (additive, recessive, dominant and
allelic) in an independent family-based study.
RESULTS
The GWA was analysed for the four genetic models additive,
recessive, dominant and allelic. By sorting all analysed SNPs with a
MAF $10% by minimal nominal p-values a list was derived for
the best 15 SNPs (Table 1). Six SNPs (rs1121980, rs9939973,
rs7193144, rs9940128, rs8050136, rs9939609, pair-wise r
2 range
0.88–1) in FTO were among these 15 best SNPs of the scan (see
Table 1); all six SNPs localize to the same linkage disequilibrium
(LD) block. FTO-SNP rs1121980 rendered the lowest nominal
p-value of 1.13610
27; this SNP was the only SNP that survived
correction for multiple testing (corrected p=0.0494; Table 1). The
log-additive OR for the rs1121980 risk T-allele was 1.66 (95% CI
1.37–2.01); the odds ratios for heterozygotes (CT) and homozy-
gotes (TT) were estimated at 1.67 (95% CI 1.22–2.27) and 2.76
(95% CI 1.88–4.03), respectively. Frequencies of the T-allele in
cases and controls were 0.53 and 0.41 (Table 1).
Eleven of the best 15 markers were subsequently genotyped in
644 independent obesity families based on at least one young
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FTO and Early Onset Obesity
PLoS ONE | www.plosone.org 2 December 2007 | Issue 12 | e1361obese index patient; of the six positive FTO SNPs belonging to the
same LD block, we genotyped only the two SNPs with the lowest
p-values. Confirmation of the initial finding using FBAT (family-
based association test) was detected for the two FTO SNPs (both
Bonferroni corrected p#0.01). However, none of the risk alleles of
the nine other SNPs showed evidence for association in the
independent families.
Additionally, similar to the approach of Scuteri et al. [8], we
analysed specific candidate genes (coding sequence plus approx-
imately 50 kb flanking the 59 and 39 regions, respectively). We
chose those candidate genes delineated in the current version of
the Obesity Gene Map Database (http://obesitygene.pbrc.edu/; [9]),
for which two or more independent positive associations to obesity
have been reported in addition to those genes listed in the
Database to harbour mutations leading to monogenic forms of
obesity. In Table S1 (Supporting Information), for each of these
genes, the SNP with the lowest p-value and the respective genetic
model are shown. Overall, among the 745 SNPs tested 75 (12) had
a p-value below 0.05 (0.01). We re-assessed the original
publications for the markers in Table S1 (Supporting Information)
which had a nominal p-value below 0.005. For three SNPs of the
previous publications (ESR1: rs2234693; rs9340799 and LDLR
rs688) HapMap data were available. Hence, we checked for linkage
disequilibrium by D’ and r
2.F o rESR1 both previously investigated
SNPs (rs2234693; rs9340799 [10,11]) were approximately 16 kb
apart from the 500k SNP rs712221. D’ was 0.321 and 0.809,
respectively, r
2 was 0.103 and 0.378, respectively. For LDLR the
previous SNP (rs688 [12,13]) was just 48 bp apart from the 500k
SNP rs1799898. D’ was 1 and r
2 was 0.144. However, the allele
frequencies of the original SNPs and the closest GWA SNPs were
quite different (e.g. rs1799898 MAF approximately 12% versus a
MAF of 45% in rs688), complicating statements dealing with
whether or not both markers tag the same disease related haplotype.
Clearly, this possibility requires further attention.
DISCUSSION
Here we show by a GWA including early onset extremely obese
cases (mean BMI Zscore 4.6362.27) and healthy underweight
controls (mean BMI Zscore 21.3860.35; BMI,15
th age
percentile) that variation in FTO strongly contributes to the
development of early onset obesity. Recently, the FTO gene was
found to be associated with T2DM as based on two GWAs [5,6].
However, after adjusting for BMI the T2DM association vanished
indicating that FTO explains variation of body weight. Confirma-
tion in 13 samples with 38,759 individuals and a meta-analysis
showed that the A-allele of the variant rs9939609 is associated with
a 31% increased risk to develop obesity [5]. These results were
independently supported in 8,000 individuals from different
populations [14] and in a GWA for obesity-related traits in an
epidemiological cohort [8]. The best SNP rs1421085 of the study
of Dina et al. [14] showed a nominal p=3.46610
27 (log-additive
OR for the risk allele 1.69, 95% CI 1.38–2.06) in a case-control
sample which also comprised obese German children. For our best
SNP rs1121980, which is located 8.3 kb upstream of rs1421085
(pairwise r
2=0.90 in CEU HAPMAP; both within intron 1), we
found similar estimated genetic effect sizes. As effect sizes for the
best markers derived from GWA data sets are usually overesti-
mated [15], our GWA data is an example that this will not always
be the case.
Given the relatively small sample size used in our GWA, this
investigation nevertheless revealed a single SNP in FTO that
remained significant after a proper control of the type I error. The
FTO SNPs have previously been shown to be relevant for obesity
in both children and adults [5,8,14]. To determine, if the finding is
present in all children or only among the older teenagers we did a
median split for age within the case group and explored the
relationship of each subgroup in comparison to controls as well as
to each other (data not shown). The effect is valid in both
subgroups and there is no difference between the subgroups.
Frayling et al. reported that the association is relevant by the age of
7 and persists into the pre-pubertal period and beyond [5]. Only a
meta-analysis addressing developmental aspects will be able to
pinpoint, if the effect of the FTO variants is more relevant for
children or for adults.
Confirmation of the 11 SNPs genotyped in 644 independent
obesity families succeeded only for the two FTO SNPs (Table 1).
Hence, our data suggest that of the best 15 SNPs of the GWA only
the FTO SNPs represent true positive findings. This is in
accordance with a population-based GWA for body weight that
also merely resulted in the initial confirmation of only one
candidate gene [8].
Our data pertaining to the candidate gene analyses (Table S1)
are not readily comparable with the previous publications, as for
instance the number of analysed individuals was quite low for
some of the previous reports. We restricted our analyses to genes
listed in the Obesity Gene Map Database (http://obesitygene.pbrc.
edu/; [9]) with at least two confirmations; the quality of the
original reports varied considerably and for some of the genes
different SNPs/variants had been analysed. Hence, we suggest
that the candidate genes with SNPs resulting in nominal p-values
below 0.005 in our scan should be followed up in subsequent
studies.
In general, this report is another proof of concept in favour of




487 extremely obese children and adolescents (‘cases’) were
recruited in hospitals specialized for the inpatient treatment of
extreme obesity (Table 2; mean BMI Z score: 4.6362.27) while
442 healthy lean individuals (‘controls’) were ascertained at the
University of Marburg (Table 2). We relied on older healthy
underweight controls to substantially reduce the probability of
their becoming overweight and to increase power [e.g. 16]. Based
on self-reported questionnaire data on body-weight course, 78% of
the lean controls reported having had a below average body
weight at age 15, which is similar to the mean age of our obese
cases. Thus, our control group mainly comprises individuals who
presumably also were in the lower body weight range during
adolescence. Details on power considerations are provided in the
Supporting Information (Text S1). Written informed consent was
given by all participants and in case of minors their parents. The
study was approved by the Ethics Committees of the Universities
of Marburg and Essen and conducted in accordance with the
guidelines of The Declaration of Helsinki.
Genotyping
Genotyping was performed on the Genome-Wide Human SNP
Array 5.0 (http://www.affymetrix.com/) at the Affymetrix
Services Lab (California, USA). 440,794 genotypes of 929
individuals (Dynamic Model algorithm call rate.86%) were
called by the BRLMM-P algorithm. For the replication of 11
SNPs genotyping was performed by matrix-assisted laser desorp-
tion ionization-time of flight mass spectrometry (MALDI-TOF
MS) analysis of allele-dependent primer extension products as
described elsewhere [17].
FTO and Early Onset Obesity
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For the GWA data, SNPs with a call rate,95%, departure from
Hardy-Weinberg equilibrium in the control group (exact test
p,0.01), or with minor allele frequency below 10 percent were
excluded from the final analysis (151,503 excluded; 289,291
retained; see Supporting Information; Text S1 and Table S2). The
statistical analyses followed the procedure of Sladek et al. [4].
Details are described in the Supporting Information (Text S1). All
reported nominal p-values of the GWA are two-sided and
asymptotic. In addition, empirical p-values corrected for ge-
nome-wide testing and maximization across genetic models are
provided. We used a genome-wide significance level of .05 (two-
sided). For the confirmation study, both nominal one-sided and
Bonferroni corrected (11 tests) p-values are presented for the risk
alleles identified in the GWA.
Confirmation
The 11 of the 15 best SNPs (ranked by p-value, irrespective of the
genetic model; see Table 1) were genotyped in 644 independent
obesity families comprising 644 extremely obese children and
adolescents (index patients) and both of their biological parents;
additionally in 297 families obese sibs were also included (for
details see Table 2). As none of the 11 SNPs showed strong
evidence for a recessive genetic model in the GWA, it was decided
to restrict the family-based association testing to the additive
model for each of the SNPs (FBAT additive) in order to reduce the
amount of multiple testing.
Candidate gene analyses
Within the GWA data we analysed genes previously suggested to
be involved in body weight regulation. We examined 745 SNPs
(located within the gene and approximately 50kb 59and 50kb 39to
the gene) in 47 candidate genes (single gene mutations with an
obesity phenotype and candidate genes associated with obesity in
at least two independent studies as shown in the Obesity Gene Map
Database; http://obesitygene.pbrc.edu/) and determined the num-
ber of SNPs with p-values # 0.05 (0.01). In addition, we provided
information on the SNP with the lowest p-value among all tested
genetic models for the respective candidate gene in Table S1
(Supporting Information). For markers which had a nominal p-
value below 0.005 we re-assessed the original publications in order
to figure out if the marker in our GWA scan matches the
information provided in the original publications.
SUPPORTING INFORMATION
Table S1 Analyses of obesity candidate genes (according to the
human obesity gene map: the 2005 update: Rankinen et al., 2006) in
the GWA approach
Found at: doi:10.1371/journal.pone.0001361.s001 (0.16 MB
DOC)
Table S2 Genotyping and quality control
Found at: doi:10.1371/journal.pone.0001361.s002 (0.08 MB
DOC)
Text S1 Genotyping and quality control; Additional information
on statistical analyses; References for the Supporting Information.
Found at: doi:10.1371/journal.pone.0001361.s003 (0.04 MB
DOC)
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